BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding BioCardia, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 2.09M | 1.66M | −434.4K (−20.7%) |
| Value | $4.09M | $4.43M | +$343.2K (+8.4%) |
New holders (5)
Institutions that held BioCardia, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lynwood Capital Management Inc. | 128,924 | $344.2K | 0.44% |
| BlackRock Inc. | 33,013 | $88.1K | 0.00% |
| Wedbush Securities Inc | 15,000 | $40.0K | 0.00% |
| Simplex Trading, LLC | 3,593 | $9.00K | 0.00% |
| WealthPLAN Partners, LLC | 25 | $67 | 0.00% |
Sold out (5)
Institutions that held BioCardia, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| AIGH Capital Management LLC | 509,151 | $994.1K |
| Worth Venture Partners, LLC | 125,600 | $246.2K |
| Susquehanna International Group, LLP | 43,696 | $85.6K |
| LPL Financial LLC | 11,050 | $21.5K |
| Aspire Private Capital, LLC | 300 | $585 |